Increasing evidence indicates that inhibition of FOXO1 in cancer cells promoted cell cycle transition and cell proliferation by upregulation of cyclin D1 (Sulzmaier and Ramos, 2013; Zhou et al., 2019). Here, CCND1 is linked to cancer.